Delivery Order SPE2DB22D2108-SPE2DB22FU2MZ

Award Date 6/8/22
Potential Completion Date 6/9/22
Potential Value $17K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,112.39 firm fixed-price contract is for the delivery of 4,562,177,932 units of Rizatriptan 10 mg Orally Disintegrating Tablets, with a completion date of September 15, 2023. This order is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $1,033.59 firm fixed-price contract is for the delivery of 18 units of Rizatriptan 10 mg Tablets. The delivery order was issued under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a wide...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,094.85, is for the delivery of 4,567,223,590 units of the drug Rizatriptan 10 mg Tablet. The contract has a completion date of February 12, 2025 and is a firm fixed-price contract. There is no set-aside designation for this award. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,607.81 firm-fixed-price delivery order is for the procurement of 4,562,547,588 units of the prescription medication Rizatriptan 5 mg Orally Disintegrating Tablets. The contract has an ultimate completion date of October 23, 2023 and does not have a set-aside designation. AmerisourceBergen...
The U.S. Defense Logistics Agency (DLA) awarded a $2,725.40 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit pharmaceutical distribution company. The contract is for the delivery of 4564043737 - Rizatriptan 10 mg tablet units to support military treatment programs. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025, which serves...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $13,088.81, is for the delivery of Rizatriptan 10mg tablets to support federal healthcare programs. The contract has a performance period through July 5, 2023 and utilizes a firm-fixed price pricing type. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,309.54, is for the delivery of Rizatriptan 10 mg Orally Disintegrating Tablets (ODT). The contract has a firm fixed price and an ultimate completion date of August 1, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order under contract SPE2DB20D7066|SPE2DB24FC2LN, awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,565,247,514 units of Rizatriptan 10 mg Orally Disintegrating Tablets (ODT) in 18-count packages. The contract is for a firm fixed price of $1,424.25 and has a completion date of July 26, 2024. This contract is not designated as a set-aside. As a large...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Rizatriptan 5 mg oral disintegrating tablets, with a ceiling value of $3,815.40 and a completion date of January 30, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,407.84 firm fixed-price delivery order is for the supply of Rizatriptan 10 mg orally disintegrating tablets, with a completion date of September 16, 2021. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999...
  • SPE2DB22D2108
    Indefinite Delivery Contract
  • SPE2DB22D2108-SPE2DB22FU2MZ
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, the Corporate Office division of AmerisourceBergen Corporation, a major pharmaceutical distribution company. The $16,797.79 firm fixed-price contract is for the supply of 4,557,473,826 units of the prescription medication Rizatriptan 10 mg tablets.

The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical. This single-award IDC serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. AmerisourceBergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000.

Generated 8/8/24, 9:55 AM